Bharat Biotech gets permission to manufacture Covaxin for sale

Credit: Mid-Day- Published on January 3, 2021
The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.

"The Central Licensing Authority has granted permission to Bharat Biotech International Ltd...

Video credit: ANI
Published on January 3, 2021 -  02:10
DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech
Drugs Controller General of India VG Somani on January 03 informed that COVID-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in emergency situation.

You are here

Related videos from verified sources

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai 01:28
Credit: ANI - Published on January 22, 2021 

First feeling, side-effects, doubts: Vaccinated doctors share experience 08:15
Credit: HT Digital Content - Published on January 16, 2021 

Bharat Biotech's consent form for Covaxin recipients says...| Oneindia News 01:05
Credit: Oneindia - Published on January 16, 2021 

Related news from verified sources

Indiaโ€™s drugs regulator DCGI on January 3 approved Oxfordโ€™s COVID-19 vaccine Covishield and Bharat Biotechโ€™s Covaxin for restricted emergency use
on January 3, 2021 • Hindu

You might like